The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Long-term survival of ipilimumab-naive patients (pts) with advanced melanoma (MEL) treated with nivolumab (anti-PD-1, BMS-936558, ONO-4538) in a phase I trial.
F. Stephen Hodi
No relevant relationships to disclose
Mario Sznol
Consultant or Advisory Role - Amgen; Anaeropharma; Bristol-Myers Squibb; Genentech; MedImmune; Nektar; Symphogen
Harriet M. Kluger
No relevant relationships to disclose
David F. McDermott
Consultant or Advisory Role - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
Richard D. Carvajal
No relevant relationships to disclose
Donald P. Lawrence
No relevant relationships to disclose
Suzanne Louise Topalian
Consultant or Advisory Role - Bristol-Myers Squibb (U); Jounce Therapeutics; Sanofi
Research Funding - Bristol-Myers Squibb
Other Remuneration - Amplimmune (I); Bristol-Myers Squibb (I)
Michael B. Atkins
Consultant or Advisory Role - Bristol-Myers Squibb
Honoraria - Bristol-Myers Squibb
John D. Powderly
Employment or Leadership Position - Biologics Human Application Lab
Consultant or Advisory Role - Amplimmune; Bristol-Myers Squibb; Genentech; Merck
Honoraria - Bristol-Myers Squibb
Research Funding - Amplimmune; Bristol-Myers Squibb; Genentech; Merck
Other Remuneration - Bristol-Myers Squibb
William Howard Sharfman
No relevant relationships to disclose
Igor Puzanov
No relevant relationships to disclose
David C. Smith
Research Funding - Bristol-Myers Squibb
Philip D. Leming
No relevant relationships to disclose
Evan J. Lipson
No relevant relationships to disclose
Janis M. Taube
Consultant or Advisory Role - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
Robert Anders
Research Funding - Bristol-Myers Squibb
Christine E. Horak
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
Georgia Kollia
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
Ashok Kumar Gupta
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
Jeffrey Alan Sosman
Consultant or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline
Honoraria - Amgen; GlaxoSmithKline
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; Novartis